HYTN Innovations Inc. announced that its wholly owned subsidiary, HYTN Cannabis Inc., has been awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers. National sales of HYTN's cannabis-infused sparkling beverages had already begun through a partnership agreement with Emerald Health Therapeutics Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.345 CAD | -15.85% | -11.54% | +392.86% |
1st Jan change | Capi. | |
---|---|---|
+392.86% | 19.46M | |
+6.52% | 270B | |
+3.18% | 46.6B | |
+28.83% | 24.77B | |
-2.76% | 16.76B | |
+14.60% | 14.56B | |
+17.14% | 12.42B | |
+2.65% | 11.11B | |
+22.09% | 10.99B | |
+7.21% | 9.33B |
- Stock Market
- Equities
- HYTN Stock
- News HYTN Innovations Inc.
- HYTN Innovations Inc. Announces its Wholly Owned Subsidiary, HYTN Cannabis Inc. Receives Approval for the Sale of Cannabis to Provincially and Territorially Authorized Retailers